REmote Ischemic COnditioning in Septic Shock (RECO-Sepsis)

July 25, 2022 updated by: Hospices Civils de Lyon

REmote Ischemic COnditioning in Septic Shock: The RECO-Sepsis Study

Septic shock remains a major public health problem in industrialized countries, with a mortality rate as high as 50%, largely related to multiple organ dysfunction. In addition to dysregulated inflammatory response, the pathophysiology of organ failures in septic shock involves ischemia-reperfusion processes. Remote ischemic conditioning is a therapeutic strategy for protecting organs against the detrimental effects of ischemia-reperfusion injury.

The objective of the present study is to determine whether remote ischemic conditioning can limit the severity of organ failure in patients with septic shock.

Study Overview

Study Type

Interventional

Enrollment (Actual)

180

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Clermont-Ferrand, France
        • CHU de Clermont-Ferrand
      • Grenoble, France
        • CHU de Grenoble
      • Lyon, France
        • Hôpital Edouard Herriot
      • Montpellier, France
        • CHU de Montpellier
      • Roanne, France
        • CH de Roanne
      • Saint-Étienne, France
        • CHU de Saint-Etienne

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Age ≥ 18 years
  • Hospitalization in an intensive care unit for less than 24 hours
  • Septic shock evolving for less than 12 hours defined as:
  • Documented or suspected infection
  • Norepinephrine administration to maintain a mean arterial pressure ≥ 65 mmHg after volemia correction
  • Lactatemia > 2 mmol/L at least once in the past 12 hours before inclusion
  • Written informed consent signed by the patient or by a next of kin or oral consent given by the patient and as soon as permitted by the clinical state written informed consent signed by the patient.

Exclusion Criteria:

  • Patient who has expressed the wish not to be resuscitated
  • Contraindication of the use of brachial cuff on both arms
  • Intercurrent pathology with an expected life expectancy of less than 24 hours
  • Cardiac arrest
  • Female patients currently pregnant or women of childbearing age who are not using contraception
  • Previous inclusion in RECO-Sepsis study
  • Previous inclusion in another clinical study
  • Patients without health coverage

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Remote ischemic conditioning
A brachial cuff is positioned around the arm of the patient. The remote ischemic conditioning consists in alternative inflations and deflations of the brachial cuff.
A brachial cuff is positioned around the arm of the patient. Four cycles of [5 min brachial cuff inflation at 200 mmHg followed by 5 min of cuff deflation] started as soon as possible after randomization. The intervention is repeated at 12 and 24 hours after inclusion.
Other: Control group
A brachial cuff is positioned around the arm of the patient. No inflation or deflation is made.
A brachial cuff is positioned around the arm of the patient and no inflation or deflation is made.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Average SOFA score (Sequential Organ Failure Assessment)
Time Frame: 96 hours.
The SOFA score ranges from 0 to 24 (higher scores indicate more severe organ failure), with 0 to 4 points assigned for each of 6 organ dysfunctions (ie, central nervous system, cardiovascular, respiratory, renal, coagulation, and liver).
96 hours.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Average SOFA score without the neurologic sub-score.
Time Frame: 96 hours.
The SOFA score without the neurologic subscore ranges from 0 to 20 (higher scores indicate more severe organ failure), with 0 to 4 points assigned for each of 5 organ dysfunctions (ie, cardiovascular, respiratory, renal, coagulation, and liver).
96 hours.
SOFA score.
Time Frame: 24 hours
24 hours
SOFA score.
Time Frame: 48 hours
48 hours
SOFA score.
Time Frame: 72 hours
72 hours
SOFA score.
Time Frame: 96 hours
96 hours
Variations of SOFA score (delta-SOFA)
Time Frame: 24 hours
24 hours
SOFA sub-scores for each organs
Time Frame: 48 hours
48 hours
SOFA sub-scores for each organs
Time Frame: 72 hours
72 hours
SOFA sub-scores for each organs
Time Frame: 96 hours
96 hours
Survival without organ support
Time Frame: Day 28
Day 28
Intensive care unit (ICU) length of stay.
Time Frame: Day 90
Day 90
Hospital length of stay
Time Frame: Day 90
Day 90
All-cause mortality
Time Frame: Day 90
Day 90

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Martin COUR, Hospices Civils de Lyon

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 28, 2017

Primary Completion (Actual)

August 12, 2019

Study Completion (Actual)

August 12, 2019

Study Registration Dates

First Submitted

June 26, 2017

First Submitted That Met QC Criteria

June 26, 2017

First Posted (Actual)

June 28, 2017

Study Record Updates

Last Update Posted (Actual)

July 26, 2022

Last Update Submitted That Met QC Criteria

July 25, 2022

Last Verified

July 1, 2022

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Septic Shock

Clinical Trials on Remote Ischemic conditioning

3
Subscribe